dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Taylor, Matthew H. |
dc.contributor.author | Aghajanian, Carol |
dc.contributor.author | Mier, James |
dc.contributor.author | Cohn, Allen L. |
dc.contributor.author | Makker, Vicky |
dc.contributor.author | OAKNIN, ANA |
dc.date.accessioned | 2021-08-23T11:25:03Z |
dc.date.available | 2021-08-23T11:25:03Z |
dc.date.issued | 2020-09-10 |
dc.identifier.citation | Makker V, Taylor MH, Aghajanian C, Oaknin A, Mier J, Cohn AL, et al. Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer. J Clin Oncol. 2020 Sep 10;38(26):2981–2992. |
dc.identifier.issn | 1527-7755 |
dc.identifier.uri | https://hdl.handle.net/11351/6231 |
dc.description | Cáncer de endometrio; Lenvatinib |
dc.language.iso | eng |
dc.publisher | American Society of Clinical Oncology |
dc.relation.ispartofseries | Journal of Clinical Oncology;38(26) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Endometri - Càncer |
dc.subject | Medicaments antineoplàstics - Ús terapèutic - Eficàcia |
dc.subject.mesh | Endometrial Neoplasms |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | /therapeutic use |
dc.title | Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1200/JCO.19.02627 |
dc.subject.decs | neoplasias endometriales |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | /uso terapéutico |
dc.relation.publishversion | https://ascopubs.org/doi/10.1200/JCO.19.02627 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Makker V, Aghajanian C] Memorial Sloan Kettering Cancer Center, New York, NY, USA. [Taylor MH] Oregon Health & Science University, Portland, OR, USA. [Oaknin A] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Mier J] Beth Israel Deaconess Medical Center, Boston, MA, USA. [Cohn AL] Rocky Mountain Cancer Center, Denver, CO, USA |
dc.identifier.pmid | 32167863 |
dc.identifier.wos | 000574584300001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |